Virpax Pharmaceuticals, Inc.
VRPXDelisted Jul 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708331
Virpax Pharmaceuticals, Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 10, 2024; 7 institutions reported holding it in 13F filings for Q1 2025, worth $34.9K in total; no superinvestor held it.
Holders of 5% or more of VRPX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Virpax Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Virpax Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Virpax Pharmaceuticals, Inc., newest first.
No Schedule 13D or 13G filings on Virpax Pharmaceuticals, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Virpax Pharmaceuticals, Inc. shares.
No Form 144 notices for Virpax Pharmaceuticals, Inc. are on file.